What was Otofarma S.P.A.’s price range in the past 12 months?
Otofarma S.P.A. lowest stock price was €2.06 and its highest was €5.48 in the past 12 months.
What is Otofarma S.P.A.’s market cap?
Otofarma S.P.A.’s market cap is €12.85M.
When is Otofarma S.P.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Otofarma S.P.A. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Otofarma S.P.A. pay dividends?
Otofarma S.P.A. does not currently pay dividends.
What is Otofarma S.P.A.’s EPS estimate?
Otofarma S.P.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Otofarma S.P.A. have?
Otofarma S.P.A. has 5,947,000 shares outstanding.
Which hedge fund is a major shareholder of Otofarma S.P.A.?
Currently, no hedge funds are holding shares in IT:OTO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Otofarma S.P.A.
Otofarma S.p.A. specializes in the manufacturing and distribution of bespoke hearing solutions. The company's comprehensive product range includes custom-fit, in-the-canal (ITC), and behind-the-ear (BTE) hearing aids, along with rechargeable options and various essential accessories. Founded in 2016, the firm's main office is located in Napoli, Italy, complemented by another branch in Milan. Effective August 5, 2025, Otofarma S.p.A. will function as a subsidiary of Bartolomucci Holding s.r.l.